Globus Medical (NYSE: GMED) reported Q3 EPS of $0.28, $0.03 better than the analyst estimate of $0.25. Revenue for the quarter came in at $137 million versus the consensus estimate of $127.46 million.

For earnings history and earnings-related data on Globus Medical (GMED) click here.